Smart pill tech aims to boost medication adherence in liver disease patients
NCT ID NCT07553377
First seen May 11, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study will test a digital pill system that tracks when people with alcohol-related liver disease take their medication and provides personalized support. The goal is to see if this approach is practical and acceptable for improving medication adherence. Fifty adults who are starting a new medication for alcohol use disorder will participate.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.